(11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET.

Maya K ArimotoTatsuya HigashiRyuichi NishiiShinya KagawaMasaaki TakahashiYoshihiko KishibeHiroshi YamauchiSatoshi IshitoyaHiroyuki OonishiYuji NakamotoKaori Togashi

Published in: Annals of nuclear medicine (2016)

MeAIB PET has better diagnostic results than FDG PET for the assessment of significant prostate cancer, and these PET studies showed complementary results. MRI has even better diagnostic results than (11)C-MeAIB PET. MeAIB accumulates in prostate cancer, which indicates that the system A amino acid transport pathway is activated in prostate cancer.

Keyphrases

prostate cancer
positron emission tomography
pet ct
computed tomography
radical prostatectomy
pet imaging
magnetic resonance imaging
amino acid
contrast enhanced
case control